Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Grand T
,
Abi Gerges S
,
David M
,
Diana MA
,
Paoletti P
.
???displayArticle.abstract???
GluN3A and GluN3B are glycine-binding subunits belonging to the NMDA receptor (NMDAR) family that can assemble with the GluN1 subunit to form unconventional receptors activated by glycine alone. Functional characterization of GluN1/GluN3 NMDARs has been difficult. Here, we uncover two modalities that have transformative properties on GluN1/GluN3A receptors. First, we identify a compound, CGP-78608, which greatly enhances GluN1/GluN3A responses, converting small and rapidly desensitizing currents into large and stable responses. Second, we show that an endogenous GluN3A disulfide bond endows GluN1/GluN3A receptors with distinct redox modulation, profoundly affecting agonist sensitivity and gating kinetics. Under reducing conditions, ambient glycine is sufficient to generate tonic receptor activation. Finally, using CGP-78608 on P8-P12 mouse hippocampal slices, we demonstrate that excitatory glycine GluN1/GluN3A NMDARs are functionally expressed in native neurons, at least in the juvenile brain. Our work opens new perspectives on the exploration of excitatory glycine receptors in brain function and development.
Fig. 1. The GluN1 antagonist CGP-78608 awakes GluN1/GluN3A receptors. a Pre-application of CGP-78608 massively potentiates excitatory glycine GluN1/GluN3A receptor responses. Bar graphs indicate effect on extent (Iss/Ipeak) and kinetics (τdes) of desensitization. ***P < 0.001, Student’s t-test, (n = 10); **P = 0.002, Mann–Whitney test (n = 10). b CGP-78608 potentiation dose-response curve obtained in presence of 100 µM glycine. Currents were measured at the peak. EC50 = 26.3 ± 5 nM, nH = 1.45 (n = 4–11). c Representative current traces showing the relative potentiation of various GluN1 antagonists compared to CGP-78608. Traces are normalized to the glycine-induced peak currents obtained prior to drug application. d Quantification of effects of GluN1 antagonists tested in c on peak and steady-state current levels (n = 4-6). N1-F484A refers to the GluN1-F484A mutant subunit. All recordings were performed in HEK293 cells. Data are mean ± SEM
Fig. 2. Kinetics and activity-dependence of CGP-78608 potentiation at GluN1/GluN3A receptors. a CGP-78608 washout kinetics in the presence of continuous or pulses of glycine. CGP-78608 was applied at 500 nM. Bar graph: comparison of the CGP-78608 washout kinetics in the active (upper trace) or resting state (lower trace). n.s. P = 0.198, Student’s t-test; (n = 4-6). b CGP-78608 potentiation is state-dependent. Potentiation by CGP-78608 (500 nM) is greatly reduced when the compound is applied after, rather than before, application of glycine (pre-Gly vs post-Gly, respectively). Bar graph: potentiation measured at steady-state. **P = 0.008, Mann–Whitney test, (n = 5). Data are mean ± SEM
Fig. 3. GluN1/GluN3A receptors display strong redox sensitivity. a Structure of the GluN1 and GluN3A ABDs (PDB 4KCC and 4KCD, respectively55). Cysteines involved in endogenous redox-sensitive disulfide bridges are highlighted (sulfur atoms shown in yellow). The central cartoon illustrates domain organization in GluN1/GluN3A receptors; NTD, N-terminal domain; ABD, agonist-binding domain; TMD, transmembrane domain; CTD, C-terminal domain. b Effect of TCEP treatment (5 mM, 20 min) on wild-type and mutant GluN1/GluN3A receptors expressed in HEK 293 cells. Glycine was applied at 100 µM. Each trace comes from a separate cell. c Quantification of tail currents observed upon washout of glycine on wild-type and mutant GluN1/GluN3A receptors. Inset indicates current tags used for quantification. n.s. P = 0.125 and 0.337, Student’s t-test (n = 4–9). Note that non-treated receptors containing wild-type GluN3A subunits do not exhibit tail currents. Data are mean ± SEM. d Effect of reduced glutathione (GSH, 50 mM for 20 min) on wild-type GluN1/GluN3A receptors expressed in HEK293 cells. Glycine was applied at 100 µM. e Effect of TCEP treatment (5 mM, 20 min) on wild-type GluN1/GluN3A receptors expressed in Xenopus oocytes. The pair of current traces corresponds to responses before and after TCEP treatment on the same cell. Glycine was applied at 100 µM
Fig. 4. High-glycine sensitivity and tonic activation of reduced GluN1/GluN3A receptors. a Glycine deactivation kinetics of wild-type and mutant receptors in presence of CGP-78608 (500 nM). Glycine was applied at 100 µM. b Quantification of glycine deactivation kinetics. *P = 0.027, Student’s t-test; ***P < 0.001, Student’s t-test (n = 4–7). Inset: representative current traces and overlaid fits following glycine washout. c Quantification of glycine-induced steady-state outward current shifts following TCEP treatment (see Text). Currents at steady-state (I1) are expressed as percentage of I0 current (see Fig. 2c). ***P < 0.001, Student’s t-test; n.s. P = 0.95 and 0.49, respectively, Student’s t-test; (n = 4–9). d Effect of CNQX (50 µM) on the holding current (current measured in the absence of glycine) for both wild-type and mutant GluN1-CS-CS/GluN3A-CS-CS receptors. e Effect of CNQX (50 µM) on basal and glycine-induced currents carried by GluN1-CS-CS/GluN3A-CS-CS mutant receptors. Note the strong inhibition by CNQX of the tail current (rebound current following glycine removal). Glycine was applied at 100 µM. All recordings were performed in HEK293 cells. Data are mean ± SEM
Fig. 5. GluN1/GluN3A receptors are expressed and functional in juvenile hippocampal slices. a Schematic representation of the experimental protocol. Glycine (10 mM) is puffed onto voltage-clamped CA1 cells in acute hippocampal slices from young (P8-12) mice. b In control conditions, glycine puffs trigger very small inward currents in both wild-type (WT) and GluN3A-KO mice (upper black traces on both left and right). A typical response obtained in WT mice is shown at larger magnification and time scale in the top left inset. Bath application of CGP-78608 (CGP) leads to massive potentiation of glycine-elicited currents in WT mice, but has no effect in GluN3A-KO animals (bottom red traces). In WT mice, addition of DCKA (500 µM), a GluN1 and GluN3A glycine-binding site antagonist, eliminates currents obtained in the presence of CGP-78608 (bottom left green trace), thus further confirming that GluN1/GluN3A receptors mediate the responses to glycine. c Quantification of the experimental results obtained in panel b. WT mice, full bars; GluN3A-KO mice, empty bars. Data are illustrated as mean ± SEM
Fig. 6. Schematic model of GluN1/GluN3A activation and modulation. For clarity, a single GluN1/GluN3A dimer is shown and the NTDs omitted. The upper scheme (a) shows receptor activation in control conditions. The GluN3A disulfide bridge conferring high redox sensitivity is highlighted in pink. The lower left scheme (b) illustrates activation sequence in presence of CGP-78608. Pre indicates application of CGP-78608 before glycine application while Post indicates the opposite. Pre-incubation with CGP-78608 prior to glycine application enhances receptor activity by preventing glycine binding to GluN1 and subsequent entry into desensitized states. The lower right scheme (c) illustrates activation sequence of reduced receptors (GluN3A ABD lower lobe disulfide bridge broken). The main modification is a large increase in the affinity of the GluN3A ABD for glycine resulting in tonic receptor activation by ambient glycine
Aizenman,
Selective modulation of NMDA responses by reduction and oxidation.
1989, Pubmed
Aizenman,
Selective modulation of NMDA responses by reduction and oxidation.
1989,
Pubmed
Andersson,
Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B.
2001,
Pubmed
Auberson,
N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and NMDA(glycine) antagonists.
1999,
Pubmed
Awobuluyi,
Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors.
2007,
Pubmed
Baron,
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
1992,
Pubmed
Bliss,
A synaptic model of memory: long-term potentiation in the hippocampus.
1993,
Pubmed
Bowery,
GABA and glycine as neurotransmitters: a brief history.
2006,
Pubmed
Chatterton,
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
2002,
Pubmed
,
Xenbase
Choi,
Redox modulation of the NMDA receptor.
2000,
Pubmed
Ciabarra,
Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family.
1995,
Pubmed
,
Xenbase
Cummings,
Residues in the GluN1 C-terminal domain control kinetics and pharmacology of GluN1/GluN3A N-methyl-d-aspartate receptors.
2017,
Pubmed
Cummings,
Protons Potentiate GluN1/GluN3A Currents by Attenuating Their Desensitisation.
2016,
Pubmed
Curtis,
Inhibition of spinal neurons by glycine.
1967,
Pubmed
Das,
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A.
1998,
Pubmed
,
Xenbase
Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed
Guzmán,
A gain-of-function mutation in the GRIK2 gene causes neurodevelopmental deficits.
2017,
Pubmed
Hackos,
Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences.
2017,
Pubmed
Henson,
Influence of the NR3A subunit on NMDA receptor functions.
2010,
Pubmed
Horak,
Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors.
2004,
Pubmed
Johnson,
Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons.
1992,
Pubmed
Karakas,
Crystal structure of a heterotetrameric NMDA receptor ion channel.
2014,
Pubmed
Kim,
PDI regulates seizure activity via NMDA receptor redox in rats.
2017,
Pubmed
Kleckner,
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Kumar,
Linking redox regulation of NMDAR synaptic function to cognitive decline during aging.
2013,
Pubmed
Kvist,
Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase
Köhr,
NMDA receptor channels: subunit-specific potentiation by reducing agents.
1994,
Pubmed
Larsen,
NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity.
2011,
Pubmed
Lee,
NMDA receptor structures reveal subunit arrangement and pore architecture.
2014,
Pubmed
,
Xenbase
Legendre,
The glycinergic inhibitory synapse.
2001,
Pubmed
Lerma,
Glycine decreases desensitization of N-methyl-D-aspartate (NMDA) receptors expressed in Xenopus oocytes and is required for NMDA responses.
1990,
Pubmed
,
Xenbase
Lu,
Slow AMPAR Synaptic Transmission Is Determined by Stargazin and Glutamate Transporters.
2017,
Pubmed
Madry,
Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn2+ and NR1 antagonist.
2008,
Pubmed
,
Xenbase
Madry,
Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
2007,
Pubmed
,
Xenbase
Matsuda,
Specific assembly with the NMDA receptor 3B subunit controls surface expression and calcium permeability of NMDA receptors.
2003,
Pubmed
Mesic,
The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors.
2016,
Pubmed
,
Xenbase
Mony,
Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.
2011,
Pubmed
Nishi,
Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner.
2001,
Pubmed
Otsu,
Functional Principles of Posterior Septal Inputs to the Medial Habenula.
2018,
Pubmed
Pachernegg,
GluN3 subunit-containing NMDA receptors: not just one-trick ponies.
2012,
Pubmed
Paoletti,
Molecular basis of NMDA receptor functional diversity.
2011,
Pubmed
Paoletti,
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
2013,
Pubmed
Perez-Otano,
Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors.
2001,
Pubmed
Piña-Crespo,
Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits.
2010,
Pubmed
Pérez-Otaño,
Emerging roles of GluN3-containing NMDA receptors in the CNS.
2016,
Pubmed
Roberts,
Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation.
2009,
Pubmed
Sanchez,
Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures.
2000,
Pubmed
Sanz-Clemente,
Diversity in NMDA receptor composition: many regulators, many consequences.
2013,
Pubmed
Sasaki,
Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons.
2002,
Pubmed
,
Xenbase
Semyanov,
Tonically active GABA A receptors: modulating gain and maintaining the tone.
2004,
Pubmed
Smothers,
Expression of glycine-activated diheteromeric NR1/NR3 receptors in human embryonic kidney 293 cells Is NR1 splice variant-dependent.
2009,
Pubmed
Smothers,
Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
2007,
Pubmed
Sucher,
Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain.
1995,
Pubmed
,
Xenbase
Sullivan,
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor.
1994,
Pubmed
,
Xenbase
Sun,
Mechanism of glutamate receptor desensitization.
2002,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Wee,
Immunolocalization of NMDA receptor subunit NR3B in selected structures in the rat forebrain, cerebellum, and lumbar spinal cord.
2008,
Pubmed
Wong,
Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain.
2002,
Pubmed
Yang,
Reversal of aging-associated hippocampal synaptic plasticity deficits by reductants via regulation of thiol redox and NMDA receptor function.
2010,
Pubmed
Yao,
Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors.
2008,
Pubmed
Yao,
Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A.
2006,
Pubmed
Yao,
Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.
2013,
Pubmed
Yi,
Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
2016,
Pubmed
,
Xenbase